Loading...
Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients
Trabectedin and ifosfamide are among the few cytostatic agents active in advanced soft tissue sarcomas (STSs). Trabectedin is most potent against so-called L-sarcomas (leiomyosarcoma and liposarcoma). The survival gain and cost-effectiveness of these agents in a second-line setting were analysed in...
Na minha lista:
| Udgivet i: | Sarcoma |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589299/ https://ncbi.nlm.nih.gov/pubmed/31281207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3234205 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|